CN Patent

CN114848603B — 一种伐地那非冻干闪释片及其制备工艺

Assigned to Hubei Feirui Biopharmaceutical Co ltd · Expires 2023-12-12 · 2y expired

What this patent protects

本发明公开了一种伐地那非冻干闪释片及其制备方法，该冻干闪释片以重量份数计由如下成分组成：伐地那非5‑15份，甘露醇14‑17.5份，普鲁兰多糖16.5‑18.5份，三氯蔗糖0.3‑1.4份以及适量的水。本发明提供的伐地那非冻干闪释片服用时无需用水，有助于保护男性隐私。本发明属于药物制剂技术领域，具体是指一种伐地那非冻干闪释片及其制备工艺。

USPTO Abstract

本发明公开了一种伐地那非冻干闪释片及其制备方法，该冻干闪释片以重量份数计由如下成分组成：伐地那非5‑15份，甘露醇14‑17.5份，普鲁兰多糖16.5‑18.5份，三氯蔗糖0.3‑1.4份以及适量的水。本发明提供的伐地那非冻干闪释片服用时无需用水，有助于保护男性隐私。本发明属于药物制剂技术领域，具体是指一种伐地那非冻干闪释片及其制备工艺。

Drugs covered by this patent

Patent Metadata

Patent number
CN114848603B
Jurisdiction
CN
Classification
—
Expires
2023-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Feirui Biopharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.